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BOYLAND, CHARLES AND GOWING (1961) reported the induction of tumours
in stock mice by the repeated intravaginal application of various constituents of
spermicidal contraceptive preparations. Of fourteen substances tested all except
three gave rise to carcinomata ofthe uterine cervix or vagina. The tumours were
of three histological types-squamous, basal cell and mucus-secreting. In most
cases the tumours were discovered when the animals were killed 18 months after
treatment began. Nine out of 10 mice in a positive control group which received
7,12-dimethylbenz(a)anthracene (DMBA) developed similar tumours, the whole
group dying within 9 months ofthe start oftreatment. It was difficult to evaluate
the experiment, however, since carcinomata were also seen in a high proportion
of mice treated with carbowax 1000, the vehicle used both for the fourteen test
substances and for the positive control group. In a second test carbowax 1000
again gave rise to carcinomata though in lower yield. When the carbowax was,
by adding sodium chloride, made isotonic (0.8% NaCl) or hypertonic (30%NaCl)
tumour incidence was increased.
Because of the results of these earlier tests and the difficulties of interpreting
them it seemed desirable to undertake further tests of the same substances using
a different vehicle.
MATERIALS AND METHODS
Mice.-240 BALB/c 5-6 week old female mice were allotted at random to
11 groups, 9 of 20 and 2 of 30. During the experiment they were housed 5 to a
cage in zinc boxes, fed Diet 41 B (obtained from Messrs. E. Dixon & Sons (Ware)
Ltd.) and given water ad libitum.
Chemical materials.-Boric acid (analar grade), gum tragacanth, 8-hydroxy-
quinoline, phenyl mercuric acetate, and quinine sulphate were obtained from
British Drug Houses; ricinoleic acid and toluquinone from Messrs. Hopkin and
Williams; hexyl resorcinol from Koch-Lights Laboratories; sodium p-toluene
sulphonchloramide (chloramine T) from Messrs. May and Baker; and 7,12-
dimethylbenz(a)anthracene from Roche Chemicals.
Treatment ofmice.-Each mouse was injected intravaginally twice a week with
0-1 ml. ofthe test substance dissolved or suspended in gum tragacanth. Injection
was made by Luer-type tuberculin syringe to the end of which was attached a
record-needle adaptor. A single, initially sterile, syringe and adaptor was used for
each treatment group on each occasion that treatment was given.CARCINOGENICITY OF SPERMICIDES
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Details of dosage are shown in Table I. Unfortunately on two occasions early
in the experiment animals were injected with the wrong substance. The first
mistake necessitated the replacement of 3 entire groups (Groups, 3, 6, and 9).
The second mistake was less serious and necessitated the replacement of only 5
mice in Group 5. Shortage of space made it impossible to set up further control
groups at this time, so that in the interpretation of the results it must be taken
into account that the Groups 0, 1 and 2 are not strictly valid controls for the
substitute mice.
TABLE I.-Details of Treatment
Number
of mice
(BALB/c
Group strain)
0 (Untreated . 30
control)
1 (Vehicle . 30
control)
2 (Positive . 20
control)
3 . 20t
4 . 20
5 . 201
6 . 20t
7 . 20
8 . 20
9 . 20t
10 . 20
Intravaginal treatment
(twice weekly as
solution/suspension in
gum tragacanth)
None
Gum tragacanth only
0.3% DMBA*
1% Hexyl resorcinol
1% 8-Hydroxyquinoline
2% Ricinoleic acid
0.3% Quinine sulphate
0.5% Phenyl mercuric acetate
0.3% Toluquinone
1% Sodium p-toluene sulphonchloramide
2% Boric acid
Number of injections
None
100
62
62
100
100
80
100
100
80
100
* 7,12-dimethylbenz(a)anthracene.
t All animals of different batch from controls (see text).
t Five animals of different batch from controls (see text).
RESULTS
The results of the experiment are shown in Tables II-IV,
lesions of the genital tract illustrated in Fig. 1-3.
and the neoplastic
DISCUSSION
The fact that 75% of the mice in the positive control group developed malig-
nant tumours of the vagina and/or perineal skin is unremarkable. All the
carcinomata were of the squamous variety though areas of some showed marked
dedifferentiation or anaplasia. Where the cervix was involved it seemed to be
only secondarily so, by invasion of tumours arising in the vagina. The fact that
no tumours arising in the cervix were observed may indicate that the method of
administration involved greater exposure of the vaginal epithelium than of the
cervix. Alternatively the vaginal epithelium may be more sensitive to the
carcinogenic effect of DMBA than the cervical epithelium, or tumour-induction
in the cervix may take longer than in the vagina. Certainly many workers have
shown that cervical cancer may be induced by careful application of carcinogenic
polycylic hydrocarbons such as DMBA to the cervix under direct vision (e.g.
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TABLE II.-Neoplasms and Hyperplastic Lesions of Corpus Uteri, Cervix Uteri, Vagina and
Perineal Skin
Test substance
Deaths with and without hyperplastic or neoplastic genital lesion*t
Time of death (months)
I,
0-4 4-6 6-8 8-10 10-12 12-14 14-16 16-18 18-20 Total
. No treatment . with tumour
without tumour
Gum tragacanth . with tumour
without tumour
. DMBA with tumour
without tumour
Hexyl resorcinol . with tumour
without tumour
8-Hydroxyquinoline with tumour
without tumour
Ricinoleic acid . with tumour
without tumour
Quinine sulphate . with tumour
without tumour
. Phenyl mercuric with tumour
acetate without tumour
Toluquinone . with tumour
without tumour
. Sodium p-toluene . with tumour
sulphonchloramide . without tumour
. Boric acid . with tumour
without tumour
2 3
3- 2
4(C) 11(C)
1 2 2
2 1
2-
2 1
1
6
2
3 1
1
1(B)
1 2
1
3 2
1(A) 1(A)
8 13 29
0
2 5 17 30
15(C)
5
1(C) 1(C)
13 19
1(B) 1(B)
5 9 19
0
6 3 5 20
0
10 9 20
1(B)
1 4 13 19
1(B) 1(B)
2 4 10 19
1(A) - 1(A)
11 7 19
1(C) 1(C)
5 8 19
* Key A-Corpus uteri and uterine horns
B-Cervix uteri
C-Vagina i perineal skin
t Included in the totals of animals "without" tumours are 11 mice (not more than 2 from any group) in which
decomposition prevented full post mortem examination. They are included in this table on the grounds that no
genital tumour was observed at time of treatment just before death.
Koprowska et al., 1958; Reagan and Wentz, 1959; see also Scarpelli and von
Haam, 1960, for review).
The two cases of polyp of the uterine horns (1 in Group 0-untreated control;
and 1 in Group 9-sodium p-toluene sulphonchloramide) are also unremarkable.
Such lesions are seen from time to time in BALB/c mice.
There remain 5 neoplastic lesions which could be attributed to treatment with
test substances. These include 2 cases of carcinoma of the cervix, one following
treatment for 13 monthswith 0.5%phenyl mercuric acetate (Group 7), and another
following treatment for 18 months with 0.3% toluquinone (Group 8). One mouse
treated with 1% 8-hydroxyquinoline (Group 4) for 18 months developed a benign
EXPLANATION OF PLATE
FIG. 1.-Well-differentiated squamous carcinoma arising near cervix of a mouse of Group 8,
given twice weeklyintravaginal injections of0.3% toluquinone suspended in gum tragacanth.
H. and E. x 65.
FIG. 2.-Squamous-tumour considered to be of low grade malignancy arising in vagina of a
mouse of Group 10, given twice weekly intravaginal injections of 2% boric acid suspended
in gum tragacanth. H. and E. x 65.
FIG. 3.-Benign polyp in horn ofuterus of a mouse of Group 9 given twice weekly intravaginal
injections of 1% sodium p-toluene sulphonchloramide suspended in gum tragacanth.
H.andE. X15.
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squamous papilloma of the cervix. The fourth neoplasm was a squamous car-
cinoma of the vagina in a mouse treated for 15 months with 1% hexyl resorcinol.
Finally a squamous tumour judged to be oflow grade malignancy was encountered
in a mouse treated with 2% boric acid for 18 months (Group 10).
Marked inflammatory infiltration by polymorphonuclear leucocytes and to a
lesser extent by lymphocytes and plasma cells ofthe cervix and vaginal wall with
epithelial hyperplasia was a feature of all treated mice. This inflammation was
only partly attributable to treatment since inflammatory changes and epithelial
hyperplasia also occurred, though in lesser degree in most of the untreated mice
TABLE III.-Histopathology of Neoplasms of Genital Tract
Grolut) Treatment
0 None
2 DMBA
Number of
mice with
genital tract
tumours
3 . Hexyl resorcinol
4 8-Hydroxyquinoline .
7 . Phenyl mercuric
acetate
.S Toluquinone
9 Sodium p-toluene
sulplionchloramide
10 Bo'ic acid
1 C
15 . V
I
V
. Cl
C(
1
1
1
Time of
Site of death
tumours (months) Histological appearances
orpus uteri 20 Polypoid hyperplasia
'agina 1 at 5 All squamous or undiffer-
perineal 3 at 6 entiated carcinomata.
skin . (i at 7 . One had metastasised to
3 at 8 a lumbar lymph node.
agina 15 Squamous carcinoma
ervix uteri 20 Benignsquamouspapilloma
ervix uteri . 14 Early squamous carcinoma
I . Cervix uteri . 18 . Keratinized squamous car-
cinoma
1 Corpus uteri . 17 . Polyp.
1 Vagina 20 . Squamous tumour of low
grade malignancy
TABLE IV.-Incidence of Tumnours at Other Sites
(Grroulj Treatment
0 Nonie
I Gum tragacanth
2 D.I13A
3 Hoxyl resorcinol
4 8-Hydroxyquinoline
5 Ricitnoleic acid
6 Quinine sulphate
Phenyl mercuric
acetate
8 Toluquinone
9) Sodium p-toluene
sulphonchloramide
10 Boric acid
* Lung adenoma also present
Mice
examined
post mortem
between
14th & 20th
month of
experiment
20
24
0
14
14
13
Mice
dying
between
10th & 14th
month with
neoplasms
I1 chronic
myeloid
leukaemia
0
0
2 lung
adenomas
0
1 lung
adenoma
] mammary.
tumour
0
Mice
with lung
adenoma or
adeno-
carcinoma
9
6
0
1
10
Mice with
malignant
lymphoma
or
reticulin
cell
sarcoma
. 3*
9
0
0
0
I
2(1*)
1*
* 1
* 1
0
19
Mice
with
mammary
adeno-
carcinoma
0
* 1
* ()
0
* 0
* 0
* 0
* 0
* 0
* 0
O
16
16
19'
0
0
* 5
7
,5 adeno-
carcinoma
of lung
14 4
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of Group 0. Under the circumstances the possibility that non-specific inflam-
mation played a role in the genesis of the tumours of the genital tract in the test
groups cannot be excluded.
The experiment was of course, not designed to study the effects of the test
compounds on tissues other than the genital tract, and the data in this connection
are difficult to interpret in so far as the animals of different groups died at different
times. The majority of tumours were adenomas or adenocarcinomas of lung,
lymphomas or reticulum cell sarcomas. In addition mammary tumours were seen
in two mice and chronic myeloid leukaemia in one. Only in Group 5 (ricinoleic
acid) was there an obvious excess of tumours. In this group 10 of the 13 mice
killed after the 14th month oftreatment had lung adenomas, all apparently benign.
This incidence was higher than in any other group including the gum tragacanth
controls (Group 1). However, the difference between Group 5 and Group 0 was
not statistically different (x2 = 2-42, 0O2 > P> 0.1), and there was no tendency
for the adenoma-bearing mice in Group 5 to have a higher average number of
tumour nodules per mouse than the controls.
Clearly none of the substances tested showed evidence of potent carcinogenicity.
The few genital tract tumours seen may indicate marginal carcinogenic activity
of the substances tested. Alternatively, they may have been due in part or
entirely to chronic inflammatory changes resulting non-specifically from treatment.
Gum tragacanth proved to be a more suitable vehicle than Carbowax 1000 as used
by Boyland, Charles and Gowing (1961).
Hoch-Ligeti (1957) administered 2 different spermicidal contraceptive prepara-
tions either orally or intravaginally to rats. In rats fed a full diet no excess in
tumour incidence was seen, but in rats fed a protein deficient diet a significantly
raised incidence of tumours of various sites was seen irrespective of the route of
administration of the test material. The tumours arose at many different sites
including lung, kidney, stomach, gut, pancreas, uterus, brain and pituitary. One
of the two preparations containing 8-hydroxyquinoline (Formula given as: boric
acid-20%, oxyquinoline benzoate 0.020%, phenyl mercuric acetate- 0020% in an
emulsion of stearic acid, cetyl alcohol, glycerin, perfume and de-ionized water,
pH- 44) was somewhat more active than the other (Formula: ricinoleic acid-
0 7 p-diisobutyl phenoxypolyethoxyethanol-I%, boric acid-3%,, in unstated
vehicle, pH 4.5).
Hueper (1965), because of Hoch-Ligeti's findings and because Boyland and
Watson (1956) had reported the induction of bladder tumours in mice which had
received intravesical implants of cholesterol pellets containing 20% 8-hydroxy-
quinoline, tested the latter suspended in aqueous gelatin in both rats and mice,
administering it by intravaginal or intrarectal instillation. Four cases of endo-
metrial carcinoma and 7 of endometrial hyperplasia were seen among 30 rats given
the test substance intravaginally. In 30 controls which received aqueous gelatin
only, there was one case of endometrial carcinoma, one of endometrial hyperplasia
and one of squamous metaplasia of the endometrium.. Intrarectal administration
in rats gave equivocal results and neither intravaginal nor intrarectal treatment
elicited a carcinogenic response in mice. It should be noted that the concentration
of 8-hydroxyquinoline used by Hueper (20%) was much higher than that used by
us (1%).
The results ofthe experiments reported here are themselves equivocal: without
being clearly negative they provided no definite evidence of the carcinogenicity
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of any of the test substances. It remains necessary to regard them, particularly
8-hydroxyquinoline, with suspicion.
SUMMARY
Groups of 20 BALB/c mice were given repeated intravaginal injections of 8
different constituents of proprietary spermicidal preparations suspended in gum
tragacanth. One mouse treated with hexyl resorcinol, one with phenyl mercuric
acetate, one with toluquinone and one with boric acid developed squamous
carcinomata ofthe cervix or vagina, after between 14 and 20 months. In addition,
one mouse treated with 8-hydroxyquinoline developed a squamous papilloma ofthe
cervix after 20 months. No such tumours arose in response to ricinoleic acid,
quinine sulphate, or sodium p-toluene sulphonchloramide or to gum tragacanth
alone (30 mice), nor were tumours seen in 30 untreated mice. In response to
7,12-dimethylbenz(a)anthracene 15 out of 20 mice developed squamous carcino-
mata of the vagina or perineal skin within 8 months of the start of treatment.
Marked chronic inflammation ofthe genital tract was present in a high proportion
of mice and may have played a role in aetiology of the tumours which arose.
The findings are discussed in the light of previous work.
We are grateful to Dr. Noel Gowing and Dr. Ursula Rowlatt for their opinion
with regard to some of the histopathological material. Our thanks are due to
Miss Anne Walsh and Mrs. Ruth Hickman for skilled technical assistance, to the
staffs of the histology and photographic departments, and to Miss Marjorie Butt
for help in preparing the manuscript.
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